Journal of Vascular Surgery
Volume 48, Issue 4 , Pages 912-917 , October 2008

N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery

  • Sriram Rajagopalan, MBBS, MRCS

      Affiliations

    • Department of Vascular Surgery, University of Aberdeen and Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom
    • Corresponding Author InformationReprint requests: Sriram Rajagopalan, MBBS, MRCS, Specialist Registrar-Vascular Unit, Aberdeen Royal Infirmary, Foresterhill, AB25 2ZN, UK
    • ,
  • Bernard L. Croal, MD, MRCP, MRCPath

      Affiliations

    • Department of Clinical Biochemistry, University of Aberdeen and Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom
    • ,
  • Paul Bachoo, FRCS

      Affiliations

    • Department of Vascular Surgery, University of Aberdeen and Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom
    • ,
  • Graham S. Hillis, MRCP, PhD

      Affiliations

    • Department of Cardiology, University of Aberdeen and Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom
    • ,
  • Brian H. Cuthbertson, FRCA

      Affiliations

    • Health Services Research Unit, University of Aberdeen and Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom
    • ,
  • Julie Brittenden, MD, FRCS

      Affiliations

    • Department of Vascular Surgery, University of Aberdeen and Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, United Kingdom

Received 20 February 2008 ,Accepted 5 May 2008.

References 

  1. Mangano DT, Hollenberg M, Fegert G, Meyer ML, London MJ, Tubau JF, et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery–I: Incidence and severity during the 4 day perioperative period (The Study of Perioperative Ischemia (SPI) Research Group). J Am Coll Cardiol. 1991;17:843–850
  2. Kalra M, Charlesworth D, Morris JA, al-Khaffaf H. Myocardial infarction after reconstruction of the abdominal aorta. Br J Surg. 1993;80:28–31
  3. L'Italien GJ, Cambria RP, Cutler BS, Leppo JA, Paul SD, Brewster DC, et al. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg. 1995;21:935–944
  4. Haggart PC, Adam DJ, Ludman PF, Bradbury AW. Comparison of cardiac troponin I and creatine kinase ratios in the detection of myocardial injury after aortic surgery. Br J Surg. 2001;88:1196–1200
  5. Hobbs SD, Yapanis M, Burns PJ, Wilmink AB, Bradbury AW, Adam DJ. Peri-operative myocardial injury in patients undergoing surgery for critical limb ischaemia. Eur J Vasc Endovasc Surg. 2005;29:301–304
  6. Landesberg G, Luria MH, Cotev S, Eidelman LA, Anner H, Mosseri M, et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet. 1993;341:715–719
  7. Fleisher LA, Nelson AH, Rosenbaum SH. Postoperative myocardial ischemia: etiology of cardiac morbidity or manifestation of underlying disease?. J Clin Anesth. 1995;7:97–102
  8. Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW. Myocardial infarction after noncardiac surgery. Anesthesiology. 1998;88:572–578
  9. Kim LJ, Martinez EA, Faraday N, Dorman T, Fleisher LA, Perler BA, et al. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation. 2002;106:2366–2371
  10. Landesberg G, Shatz V, Akopnik I, Wolf YG, Mayer M, Berlatzky Y, et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol. 2003;42:1547–1554
  11. Kertai MD, Boersma E, Klein J, Van Urk H, Bax JJ, Poldermans D. Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery. Eur J Vasc Endovasc Surg. 2004;28:59–66
  12. Barbagallo M, Casati A, Spadini E, Bertolizio G, Kepgang L, Tecchio T, et al. Early increases in cardiac troponin levels after major vascular surgery is associated with an increased frequency of delayed cardiac complications. J Clin Anesth. 2006;18:280–285
  13. McFalls EO, Ward HB, Moritz TE, Apple FS, Goldman S, Pierpont G, et al. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial. Eur Heart J. 2008;29:394–401
  14. Brevetti G, Silvestro A, Di Giacomo S, Bucur R, Di Donato A, Schiano V, et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg. 2003;38:374–379
  15. Karkos CD, Baguneid MS, Triposkiadis F, Athanasiou E, Spirou P. Routine measurement of radioisotope left ventricular ejection fraction prior to vascular surgery: is it worthwhile?. Eur J Vasc Endovasc Surg. 2004;27:227–238
  16. Yeh HM, Lau HP, Lin JM, Sun WZ, Wang MJ, Lai LP. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg. 2005;92:1041–1045
  17. Dernellis JM, Panaretou MP. Assessment of cardiac risk before noncardiac surgery: brain natriuretic peptide in 1590 patients. Heart. 2006;92:1645–1650
  18. Gibson SC, Payne CJ, Byrne DS, Berry C, Dargie HJ, Kingsmore DB. B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery. Br J Surg. 2007;94:903–909
  19. Cuthbertson BH, Amiri AR, Croal BL, Rajagopalan S, Alozairi O, Brittenden J, et al. Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth. 2007;99:170–176
  20. Cuthbertson BH, Amiri AR, Croal BL, Rajagopalan S, Brittenden J, Hillis GS. Utility of B-type natriuretic Peptide in predicting medium-term mortality in patients undergoing major non-cardiac surgery. Am J Cardiol. 2007;100:1310–1313
  21. Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, et al. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol. 2006;98:111–115
  22. Mahla E, Baumann A, Rehak P, Watzinger N, Vicenzi MN, Maier R, et al. N-terminal pro-brain natriuretic peptide identifies patients at high risk for adverse cardiac outcome after vascular surgery. Anesthesiology. 2007;106:1088–1095
  23. Rajagopalan S, Ford I, Bachoo P, Hillis GS, Croal B, Greaves M, et al. Platelet activation, myocardial ischemic events and post-operative non-response to aspirin in patients undergoing major vascular surgery. J Thromb Haemost. 2007;5:2028–2035
  24. Rajagopalan S, Mckay I, Ford I, Bachoo P, Greaves M, Brittenden J. Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management. J Vasc Surg. 2007;46:485–490
  25. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–1049
  26. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92:843–849
  27. Mueller T, Gegenhuber A, Dieplinger B, Poelz W, Haltmayer M. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin Chem Lab Med. 2004;42:942–944
  28. Feringa HH, Schouten O, Dunkelgrun M, Bax JJ, Boersma E, Elhendy A, et al. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery. Heart. 2007;93:226–231
  29. Devereaux PJ, Beattie WS, Choi PT, Badner NH, Guyatt GH, Villar JC, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? (Systematic review and meta-analysis of randomised controlled trials). BMJ. 2005;331:313–321

 Sriram Rajagopalan was sponsored by a grant from the Scottish Chief Scientist Office.

 The Health Services Research Unit is core funded by the Chief Scientists Office of the Scottish Executive Health Department. The views expressed in this article are entirely those of the authors.

 Competition of interest: none.

PII: S0741-5214(08)00731-3

doi: 10.1016/j.jvs.2008.05.015

Journal of Vascular Surgery
Volume 48, Issue 4 , Pages 912-917 , October 2008

Article Tools

* Image Usage & Resolution